June 19, 2020
The Japan arm of AstraZeneca on June 17 began to voluntarily recall all lots of its proton pump inhibitor (PPI) Omepral Injection 20 (omeprazole) due to flaws in the environmental monitoring data, it said on the same day. The company...read more